NCT06012227

Brief Summary

The aim of the study will be to evaluate the impact of consumption of meat and dairy products from extensive or intensive farming on apparently healthy individuals aged between 45 and 65 years, a stage of life associated with reduced metabolic flexibility and changes in lipid metabolism. The study will analyze:

  1. 1.The transcription factor PPAR-α determined by the gene expression of PPAR-α in white blood cells, variations in circulating fatty acid metabolism, and the endocannabinoid system determined by circulating analysis of N-acylethanolamine (NAE), and 2-monoacylglycerols (2-MG);
  2. 2.Metabolic flexibility, determined by indirect calorimetry in fasting condition during an incremental exercise;
  3. 3.Body composition, determined by bioimpedance analysis, waist circumference, and waist-to-hip ratio.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Jan 2022Dec 2026

Study Start

First participant enrolled

January 20, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 27, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 28, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

August 25, 2023

Completed
3.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2026

Expected
Last Updated

August 30, 2023

Status Verified

August 1, 2023

Enrollment Period

1.5 years

First QC Date

July 28, 2023

Last Update Submit

August 26, 2023

Conditions

Keywords

metabolic flexibilitylipid metabolism

Outcome Measures

Primary Outcomes (1)

  • Changes in plasma levels of DHA and acylethanolamides as Metabolic indices of PPAR-α induction increase in plasma levels of DHA

    Changes in plasma levels of DHA)and modulation of the endocannabinoid system, through the biosynthesis of AEA, PEA, and OEA. All these parameters will be assessed as pmoles/ml of plasma

    After 4 weeks of treatment, 8 weeks of washout and 4 weeks of crossover

Secondary Outcomes (1)

  • Quotient respiratory changes measurement as metabolic flexibility indices

    After 4 weeks of treatment, 8 weeks of washout and 4 weeks of crossover

Study Arms (2)

"kent'erbas" pecorino from extensive farming with crossover Arm 1

EXPERIMENTAL

This study was a 4-week, randomized, controlled, crossover clinical trial. Arm 1: Volunteers will be randomize to be allocated to eat 350g/week of "kent'erbas" pecorino from extensive farming with a crossover with arm 2 after 6 weeks of washout.

Dietary Supplement: kent'erbas cheese study

"industrial" pecorino from intensive farming with crossover Arm 2

ACTIVE COMPARATOR

This study was a 4-week, randomized, controlled, crossover clinical trial. Arm 2 : Volunteers will be randomize to be allocated to eat 350g/week of "industrial" pecorino from intensive farming for 4 weeks in total, with a crossover with arm 1 after 6 weeks of washout.

Dietary Supplement: kent'erbas cheese study

Interventions

kent'erbas cheese studyDIETARY_SUPPLEMENT

Nutritional intervention with "kent'erbas" pecorino from extensive farming with crossover and "industrial" pecorino from intensive farming

"industrial" pecorino from intensive farming with crossover Arm 2"kent'erbas" pecorino from extensive farming with crossover Arm 1

Eligibility Criteria

Age45 Years - 65 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age
  • BMI \< 27
  • waist-to-hip ratio female\<0.85; male \< 0.98

You may not qualify if:

  • metabolic diseases
  • Physical activity of competitive nature
  • Vegans and vegetarians
  • Intolerances and allergies to the foods under study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Cagliari

Monserrato, Cagliari, 09042, Italy

RECRUITING

Central Study Contacts

Sebastiano Banni

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
full professor

Study Record Dates

First Submitted

July 28, 2023

First Posted

August 25, 2023

Study Start

January 20, 2022

Primary Completion

July 27, 2023

Study Completion (Estimated)

December 20, 2026

Last Updated

August 30, 2023

Record last verified: 2023-08

Locations